Every month we send an email newsletter to our supporters sharing recent updates from our work. We publish selected portions of the newsletter on our blog to make this news more accessible to people who visit our website. For key updates from the latest installment, please see below!
If you’d like to receive the complete newsletter in your inbox each month, you can subscribe here.
It has been a tumultuous year for global health. In early 2025, the US government cut billions of dollars in foreign aid, affecting millions of people around the world and creating substantial uncertainty that continues to ripple through health and development programs around the world.
Drawing on almost two decades of cost-effectiveness research and analysis, GiveWell assessed the effects in real time and identified funding gaps where donors’ contributions could have exceptional impact. Our actions were guided by our core principles:
In response to funding shortfalls, we funded time-sensitive opportunities to ensure that cost-effective programs could continue. And in response to substantial uncertainty and in expectation of growing needs, we engaged in efforts to research new areas and prepare ourselves for the future. You can read some examples of our response later in this post.
Despite significant progress over the past several decades, malaria remains a leading cause of death globally for children under five. This year’s cuts to foreign aid funding disrupted highly effective programs to prevent malaria, such as seasonal malaria chemoprevention (SMC).
SMC provides antimalarial medication to children under the age of five during the rainy season when malaria transmission is highest, reducing their risk of dying from the disease. Malaria Consortium’s SMC program, which is one of the most cost-effective programs our researchers have identified, has been one of GiveWell’s Top Charities since 2016, and we’ve recommended more than $500 million in grants for the program since that time.
SMC is only delivered during a specific period each year when malaria transmission is highest. The campaigns require careful planning and preparation on a specified timeline to ensure that the drugs are ready to distribute during that window. The funding freeze that started in January jeopardized 2025 SMC campaigns in several countries because of the disruption to funding for these time-sensitive pre-campaign activities.
In this episode, GiveWell CEO and co-founder Elie Hassenfeld speaks with Program Officer Natalie Crispin about how GiveWell responded quickly and flexibly to ensure that SMC campaigns moved forward this year.
Every month we send an email newsletter to our supporters sharing recent updates from our work. We publish selected portions of the newsletter on our blog to make this news more accessible to people who visit our website. For key updates from the latest installment, please see below!
If you’d like to receive the complete newsletter in your inbox each month, you can subscribe here.